Stabilizers and conditioning agents to maintain peptide effectiveness
30 days (reconstituted) Mechanism Classification Primary Mechanism: NNMT (Nicotinamide N-methyltransferase) Inhibitor Target Enzyme: Nicotinamide N-methyltransferase Cellular Effect: Increases intracellular NAD+ and SAM levels Metabolic Pathway: NAD+ salvage pathway modulation Selectivity: Highly selective for NNMT (no cross-reactivity with related enzymes) Pharmacological Properties Route of Administration: Subcutaneous injection Bioavailability: High (subcutaneous)
Dihexa shows promise in animal models of dementia, potentially treating conditions like Alzheimers disease
People exploring this path usually start with a dedicated provider-guided Semax peptide program for mental clarity and stress support rather than buying compounds on their own
As the Irish like to say, "What whiskey will not cure, there is no cure for"
Hum Reprod Update 13(3):225238 Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuve LP, Rozen R (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase